Use of antipsychotics among older residents in VA nursing homes
- PMID: 23047785
- PMCID: PMC3746977
- DOI: 10.1097/MLR.0b013e31825fb21d
Use of antipsychotics among older residents in VA nursing homes
Abstract
Background: Antipsychotic medications are commonly prescribed to nursing home residents despite their well-established adverse event profiles. Because little is known about their use in Veterans Affairs (VA) nursing homes [ie, Community Living Centers (CLCs)], we assessed the prevalence and risk factors for antipsychotic use in older residents of VA CLCs.
Methods: This cross-sectional study included 3692 Veterans age 65 or older who were admitted between January 2004 and June 2005 to one of 133 VA CLCs and had a stay of ≥90 days. We used VA Pharmacy Benefits Management data to examine antipsychotic use and VA Medical SAS datasets and the Minimum Data Set to identify evidence-based indications for antipsychotic use (eg, schizophrenia, dementia with psychosis). We used multivariable logistic regression and generalized estimating equations to identify factors independently associated with antipsychotic receipt.
Results: Overall, 948/3692(25.7%) residents received an antipsychotic, of which 59.3% had an evidence-based indication for use. Residents with aggressive behavior [odds ratio (OR)=2.74, 95% confidence interval (CI), 2.04-3.67] and polypharmacy (9+ drugs; OR=1.84, 95% CI, 1.41-2.40) were more likely to receive antipsychotics, as were users of antidepressants (OR=1.37, 95% CI, 1.14-1.66), anxiolytic/hypnotics (OR=2.30, 95% CI, 1.64-3.23), or drugs for dementia (OR=1.52, 95% CI, 1.21-1.92). Those residing in Alzheimer/dementia special care units were also more likely to receive an antipsychotic (OR=1.66, 95% CI, 1.26-2.21). Veterans with dementia but no documented psychosis were as likely as those with an evidence-based indication to receive an antipsychotic (OR=1.10, 95% CI, 0.82-1.47).
Conclusions: Antipsychotic use is common among VA nursing home residents aged 65 and older, including those without a documented evidence-based indication for use. Further quality improvement efforts are needed to reduce potentially inappropriate antipsychotic prescribing.
Similar articles
-
Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents.J Am Geriatr Soc. 2011 Aug;59(8):1412-20. doi: 10.1111/j.1532-5415.2011.03522.x. Epub 2011 Aug 8. J Am Geriatr Soc. 2011. PMID: 21824120 Free PMC article.
-
Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada.Drugs Aging. 2020 Nov;37(11):817-827. doi: 10.1007/s40266-020-00799-2. Epub 2020 Sep 26. Drugs Aging. 2020. PMID: 32978758
-
Nursing homes underreport antipsychotic prescribing.Aging Ment Health. 2020 Apr;24(4):668-672. doi: 10.1080/13607863.2019.1571015. Epub 2019 Feb 6. Aging Ment Health. 2020. PMID: 30724582 Free PMC article.
-
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.BMC Geriatr. 2017 Jan 26;17(1):32. doi: 10.1186/s12877-017-0428-1. BMC Geriatr. 2017. PMID: 28122506 Free PMC article. Review.
-
Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis.Int Psychogeriatr. 2021 Oct;33(10):1083-1098. doi: 10.1017/S1041610220004032. Epub 2021 Jan 7. Int Psychogeriatr. 2021. PMID: 33407955 Review.
Cited by
-
Factors Associated with Potentially Harmful Medication Prescribing in Nursing Homes: A Scoping Review.J Am Med Dir Assoc. 2022 Sep;23(9):1589.e1-1589.e10. doi: 10.1016/j.jamda.2022.06.008. Epub 2022 Jul 20. J Am Med Dir Assoc. 2022. PMID: 35868350 Free PMC article. Review.
-
Antipsychotic initiation and new diagnoses excluded from quality-measure reporting among Veterans in community nursing homes contracted by the Veterans Health Administration in the United States.Int J Methods Psychiatr Res. 2022 Mar;31(1):e1898. doi: 10.1002/mpr.1898. Epub 2021 Nov 5. Int J Methods Psychiatr Res. 2022. PMID: 34739736 Free PMC article.
-
Pimavanserin for the treatment of psychosis in Alzheimer's disease: A literature review.World J Psychiatry. 2020 Jul 19;10(7):162-174. doi: 10.5498/wjp.v10.i7.162. eCollection 2020 Jul 19. World J Psychiatry. 2020. PMID: 32844093 Free PMC article.
-
A pharmacist-led pilot using a performance dashboard to improve psychotropic medication use in a skilled nursing facility.BMJ Open Qual. 2020 Aug;9(3):e000997. doi: 10.1136/bmjoq-2020-000997. BMJ Open Qual. 2020. PMID: 32816865 Free PMC article.
-
Early and Accurate Identification of Parkinson Disease Among US Veterans.Fed Pract. 2019 Jun;36(Suppl 4):S18-S23. Fed Pract. 2019. PMID: 31296979 Free PMC article.
References
-
- Kales HC, Zivin K, Kim HM, et al. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry. 2011 Feb;68(2):190–197. - PubMed
-
- Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005 Feb 2;293(5):596–608. - PubMed
-
- Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005 Jun 13;165(11):1280–1285. - PubMed
-
- Chen KPA, Sherer J. Antipsychotic Drug Use Among Elderly Nursing Home Residents in the United States. Am J Geriatr Pharmacother. 2008 Oct;6(4):187–197. 2008. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- 3U01 AG012553/AG/NIA NIH HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- R56AG027017/AG/NIA NIH HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R56 AG027017/AG/NIA NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
